BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7904939)

  • 1. Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation.
    Daubert C; Mabo P; Gras D; Leclercq C
    Eur Heart J; 1993 Nov; 14 Suppl H():67-73. PubMed ID: 7904939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
    Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of sotalol in supraventricular arrhythmias.
    Brugada P; Smeets JL; Brugada J; Farré J
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():619-23. PubMed ID: 2275892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotalol in patients with Wolff-Parkinson-White syndrome.
    Kunze KP; Schlüter M; Kuck KH
    Circulation; 1987 May; 75(5):1050-7. PubMed ID: 3568305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sotalol in controlling reentrant supraventricular tachycardias.
    Millar RN
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():625-9. PubMed ID: 2275893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
    Touboul P; Atallah G; Kirkorian G; Lavaud P; Mathieu MP; Dellinger A
    Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
    Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
    Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
    Aliot E; Sadoul N; De Chillou C
    Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M; Barbieri S
    G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rational bases for the therapy of supraventricular tachycardias and their management].
    Rostagno C; Bertini G; Padeletti L; Michelucci A; Del Pace S; Gensini GF
    Ann Ital Med Int; 1993; 8(4):235-43. PubMed ID: 8161480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S; Ricard P
    Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL; Jolivette DM; Fredell PA
    Am J Cardiol; 1988 Aug; 62(6):62D-66D. PubMed ID: 3136638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
    Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
    Madrid AH; Moro C; Maŕin Huerta EM; Novo L; Mestre JL
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2111-5. PubMed ID: 1279609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.